VivaMed BioPharma (VivaMed), a clinical-stage pharmaceutical company leveraging Artificial Intelligence (AI) to discover and advance repurposed and improved therapeutic assets, today announced a ...

Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies The CHAI platform extracted quantitative histomorphologic features from whole-slide images of ...

YARMOUTH, Maine – The current advance beneficiary form of noncoverage, ABN Form CMS-R-131, is scheduled to expire on Jan. 31, 2026, according to an update posted by Noridian Healthcare Solutions, the ...

Singapore’s Defence Science and Technology Agency (DSTA) and the Republic of Korea’s Korean Register (KR) have signed a Memorandum of Understanding (MOU) to co-develop a framework to strengthen ...

According to Sawyer Merritt, two Tesla Model S vehicles were recently spotted in California equipped with the same advanced validation rig that Tesla has previously used for Model Y testing across the ...

Pfizer Inc.’s Tukysa, when given as part of the initial treatment for an advanced form of breast cancer, delayed tumor growth by more than eight months, according to a study that may expand its use.

Gene expression profiles from the Gene Expression Omnibus (GEO) database were analyzed to identify differentially expressed genes (DEGs) in LARC. Mendelian randomization (MR) analysis was subsequently ...

Mediagenix, a specialist in smart content solutions, has joined the Amazon Web Services (AWS) Independent Software Vendor (ISV) Accelerate Programme (ISV). This acceptance follows the successful ...

An advanced form of LASIK (Laser-Assisted In-Situ Keratomileusis) eye surgery that uses a virtual 3D model of a person's eye appears to offer patients better vision, a new study says. About 98% of ...